In Reply.

In Reply.

Whitaker, Marcea B; Chehab, Miriam M; Chang, Christina Y; McCulley, Lynda V; Sewell, Catherine A.

Afiliação

Whitaker MB; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Rare Diseases, Pediatrics, Urologic, and Reproductive Medicine, Division of Urology, Obstetrics and Gynecology, Silver Spring, Maryland.
Chehab MM; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, Office of Pharmacovigilance and Epidemiology, Division of Pharmacovigilance II, Silver Spring, Maryland.
Chang CY; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Rare Diseases, Pediatrics, Urologic, and Reproductive Medicine, Division of Urology, Obstetrics and Gynecology, Silver Spring, Maryland.
McCulley LV; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, Office of Pharmacovigilance and Epidemiology, Division of Pharmacovigilance II, Silver Spring, Maryland.
Sewell CA; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Rare Diseases, Pediatrics, Urologic, and Reproductive Medicine, Division of Urology, Obstetrics and Gynecology, Silver Spring, Maryland.

Obstet Gynecol ; 140(4): 704, 2022 Oct 01.

Article em En | MEDLINE | ID: mdl-36356251

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article